FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular mammalian cells and mammalian cell lines with reduced load of residues of pathogens of past virus/retrovirus infections and methods for production and application of such cells are described.
EFFECT: producing improved eucaryotic cells.
36 cl, 22 dwg, 3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
PCDEXO-GS-SSB GENETIC CONSTRUCTS CONTAINING SEQUENCES ENCODING CHIMERIC SSB PROTEINS AND EXONUCLEASES OF THE BACTERIOPHAGE HOMOLOGOUS RECOMBINATION APPARATUS, COMBINED VIA A GLYCINE-SERINE POLYLINKER | 2020 |
|
RU2763747C1 |
PDE6B GENE KNOCKOUT MOUSE MODEL CREATING AND APPLYING METHOD | 2022 |
|
RU2791687C1 |
RNA-GUIDED ENGINEERING OF HUMAN GENOME | 2013 |
|
RU2699523C2 |
GENOME EDITING TOOL BASED ON LIGD PROTEIN FROM THE BACTERIUM PSEUDOMONAS PUTIDA AND CAS9 COMPLEX | 2022 |
|
RU2797049C1 |
RNA-GUIDED HUMAN GENOME ENGINEERING | 2013 |
|
RU2766685C2 |
CRISPR-CAS SYSTEMS AND METHODS OF CHANGING EXPRESSION OF GENE PRODUCTS | 2013 |
|
RU2687451C1 |
METHOD OF EDITING MAMMALIAN GENOME BY HOMOLOGOUS REPAIR | 2022 |
|
RU2808600C1 |
GUIDED RNA TRANSCRIPTION REGULATION | 2014 |
|
RU2690935C2 |
METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATION USING PAIRED GUIDE RNAS | 2015 |
|
RU2734770C2 |
DELIVERY, CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND USE IN THERAPY | 2013 |
|
RU2721275C2 |
Authors
Dates
2021-07-29—Published
2016-12-23—Filed